bioAffinity Technologies, Inc. (BIAF)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Jun 09, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
bioAffinity Technologies SG&A Expense (Quarterly) : 3.242M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Veracyte, Inc. | 50.84M |
| Quantum Cyber NV | 2.404M |
| ADMA Biologics, Inc. | 27.80M |
| Lunai Bioworks, Inc. | 1.421M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |